If not, the implications are serious as the proposed vaccine can only be ready by August 15 by fudging data or incomplete documentation. “It has lowered the credibility of ICMR, and along with that of India’s scientific community, regulatory system government, and the potential vaccine (itself)... its reputation is dented before it is even ready. “Bharat Biotech will lose all the credibility it has earned all these years with hard work,” added Rao, referring to ICMR’s Hyderabad-based partner which is working on the vaccine. “It’s obvious to everyone with a smattering of scientific knowledge that three phases of clinical trials cannot be done in 42 days. “The message is clear: all of us want a vaccine and we want a vaccine that is safe and effective.

Source: Hindustan Times July 04, 2020 18:24 UTC